
Melissa Jean Perreira
Examiner (ID: 10386, Phone: (571)272-1354 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1065 |
| Issued Applications | 491 |
| Pending Applications | 87 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19373864
[patent_doc_number] => 12065413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => PSMA targeted fluorescent agents for image guided surgery
[patent_app_type] => utility
[patent_app_number] => 17/331113
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 50
[patent_no_of_words] => 23365
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17331113
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/331113 | PSMA targeted fluorescent agents for image guided surgery | May 25, 2021 | Issued |
Array
(
[id] => 17384003
[patent_doc_number] => 20220031855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => Organic Anion Transporting Peptide-Based Cancer Imaging and Therapy
[patent_app_type] => utility
[patent_app_number] => 17/318802
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318802
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/318802 | Organic anion transporting peptide-based cancer imaging and therapy | May 11, 2021 | Issued |
Array
(
[id] => 17050710
[patent_doc_number] => 20210260144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => QUININE AND ITS USE TO GENERATE INNATE IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 17/236918
[patent_app_country] => US
[patent_app_date] => 2021-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17236918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/236918 | QUININE AND ITS USE TO GENERATE INNATE IMMUNE RESPONSE | Apr 20, 2021 | Pending |
Array
(
[id] => 18152053
[patent_doc_number] => 11565003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Mechanical opening of lipid bilayers by molecular nanomachines
[patent_app_type] => utility
[patent_app_number] => 17/233102
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 94
[patent_no_of_words] => 19271
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233102
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/233102 | Mechanical opening of lipid bilayers by molecular nanomachines | Apr 15, 2021 | Issued |
Array
(
[id] => 17273015
[patent_doc_number] => 20210379213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => Stable, concentrated radionuclide complex solutions
[patent_app_type] => utility
[patent_app_number] => 17/209122
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209122
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/209122 | Stable, concentrated radionuclide complex solutions | Mar 21, 2021 | Abandoned |
Array
(
[id] => 17273014
[patent_doc_number] => 20210379212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => Stable, concentrated radionuclide complex solutions
[patent_app_type] => utility
[patent_app_number] => 17/209121
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17209121
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/209121 | Stable, concentrated radionuclide complex solutions | Mar 21, 2021 | Abandoned |
Array
(
[id] => 17065912
[patent_doc_number] => 20210268127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => ENHANCED SURGICAL VISUALIZATION OF VIABLE TISSUE AND PEPTIDES THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/204196
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204196
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204196 | ENHANCED SURGICAL VISUALIZATION OF VIABLE TISSUE AND PEPTIDES THEREFOR | Mar 16, 2021 | Abandoned |
Array
(
[id] => 17110184
[patent_doc_number] => 20210290781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => RADIOFREQUENCY AMPLIFICATION BY STIMULATED EMISSION OF RADIATION VIA PARAHYDROGEN INDUCED POLARIZATION
[patent_app_type] => utility
[patent_app_number] => 17/202454
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/202454 | RADIOFREQUENCY AMPLIFICATION BY STIMULATED EMISSION OF RADIATION VIA PARAHYDROGEN INDUCED POLARIZATION | Mar 15, 2021 | Pending |
Array
(
[id] => 19310495
[patent_doc_number] => 12036289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Gadolinium bearing PCTA-based contrast agents
[patent_app_type] => utility
[patent_app_number] => 17/199122
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 13683
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199122
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199122 | Gadolinium bearing PCTA-based contrast agents | Mar 10, 2021 | Issued |
Array
(
[id] => 16914041
[patent_doc_number] => 20210187133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => Compounds and Methods of Making Compounds
[patent_app_type] => utility
[patent_app_number] => 17/185502
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185502
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185502 | Compounds and Methods of Making Compounds | Feb 24, 2021 | Abandoned |
Array
(
[id] => 18270570
[patent_doc_number] => 20230091812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => WHITE, BACTERIA-RESISTANT, BIOCOMPATIBLE, ADHERENT COATING FOR IMPLANTS, SCREWS AND PLATES INTEGRATED IN HARD AND SOFT TISSUE AND PRODUCTION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/795303
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795303
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795303 | WHITE, BACTERIA-RESISTANT, BIOCOMPATIBLE, ADHERENT COATING FOR IMPLANTS, SCREWS AND PLATES INTEGRATED IN HARD AND SOFT TISSUE AND PRODUCTION METHOD | Jan 24, 2021 | Abandoned |
Array
(
[id] => 19367421
[patent_doc_number] => 12059482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Activity-based probe compounds, compositions, and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/127754
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 25
[patent_no_of_words] => 14167
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127754 | Activity-based probe compounds, compositions, and methods of use | Dec 17, 2020 | Issued |
Array
(
[id] => 19060137
[patent_doc_number] => 11939345
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Physiologically stable fluorophore and performing fluorescence probing
[patent_app_type] => utility
[patent_app_number] => 17/117424
[patent_app_country] => US
[patent_app_date] => 2020-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 14981
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17117424
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/117424 | Physiologically stable fluorophore and performing fluorescence probing | Dec 9, 2020 | Issued |
Array
(
[id] => 16822795
[patent_doc_number] => 20210138088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => BISMUTH-IRON OXIDE CONTRAST AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/116596
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116596
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/116596 | BISMUTH-IRON OXIDE CONTRAST AGENTS | Dec 8, 2020 | Abandoned |
Array
(
[id] => 16726590
[patent_doc_number] => 20210093737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => SYNTHESIS AND COMPOSITION OF AMINO ACID LINKING GROUPS CONJUGATED TO COMPOUNDS USED FOR THE TARGETED IMAGING OF TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/114195
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/114195 | Synthesis and composition of non-amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Dec 6, 2020 | Issued |
Array
(
[id] => 17519357
[patent_doc_number] => 20220105205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => PSMA-TARGETED NIR DYES AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 17/112497
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112497 | PSMA-TARGETED NIR DYES AND THEIR USES | Dec 3, 2020 | Abandoned |
Array
(
[id] => 18869865
[patent_doc_number] => 11857645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Compositions of near IR closed chain, sulfo-cyanine dyes and prostate specific membrane antigen ligands
[patent_app_type] => utility
[patent_app_number] => 17/112075
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 10136
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112075
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112075 | Compositions of near IR closed chain, sulfo-cyanine dyes and prostate specific membrane antigen ligands | Dec 3, 2020 | Issued |
Array
(
[id] => 17110182
[patent_doc_number] => 20210290779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => DIAGNOSIS AND TREATMENT FOR RESPIRATORY TRACT DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/111158
[patent_app_country] => US
[patent_app_date] => 2020-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17111158
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/111158 | DIAGNOSIS AND TREATMENT FOR RESPIRATORY TRACT DISEASES | Dec 2, 2020 | Pending |
Array
(
[id] => 19550208
[patent_doc_number] => 12133900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-05
[patent_title] => Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
[patent_app_type] => utility
[patent_app_number] => 17/105308
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 90
[patent_figures_cnt] => 109
[patent_no_of_words] => 29348
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17105308
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/105308 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Nov 24, 2020 | Issued |
Array
(
[id] => 19104693
[patent_doc_number] => 11957766
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => HNQO1-activatable fluorescent probe for imaging cancer cells in-vitro and in-vivo
[patent_app_type] => utility
[patent_app_number] => 16/950107
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 33
[patent_no_of_words] => 16190
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16950107
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/950107 | HNQO1-activatable fluorescent probe for imaging cancer cells in-vitro and in-vivo | Nov 16, 2020 | Issued |